Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
Public ClinicalTrials.gov record NCT00110708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-Controlled Phase II Trial Evaluating Safety and Efficacy of Oral Human Immunoglobulin in the Treatment of Gastrointestinal Dysfunction Associated With Autistic Disorder in Pediatric Patients From 2 to 18 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if human immunoglobulin given by mouth twice a day is effective in treating the persistent gastrointestinal (GI) problems such as diarrhea, constipation, abdominal pain, and bloating, in children with autism.
Study identification
- NCT ID
- NCT00110708
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Jun 2006 (Type not available)
- Last update posted
- Feb 22, 2006
2005 – 2006
United States locations
- U.S. sites
- 22
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Autism Research and Resource Center | Phoenix | Arizona | 85006 | — |
| Center for Autism Research and Education | Phoenix | Arizona | 85012 | — |
| University of California Davis, MIND Institute | Sacramento | California | 95817 | — |
| Sarkis Clinical Trials | Gainesville | Florida | 32607 | — |
| University of Florida HSC | Gainesville | Florida | 32608 | — |
| International Child Development Resource Center | Melbourne | Florida | 32901 | — |
| Medical Research Group of Central Florida | Orange City | Florida | 32763 | — |
| Riley Hospital for Children | Indianapolis | Indiana | 46202 | — |
| University of Kansas Medical Center, Developmental Disabilities Center | Kansas City | Kansas | 66160 | — |
| Bluegrass Clinical Research | Louisville | Kentucky | 40291 | — |
| Gulf Coast Research, LLC | Baton Rouge | Louisiana | 70808 | — |
| Hardy Health Associates | Hingham | Massachusetts | 02043 | — |
| Pivotal Research Centers - Detroit | Royal Oak | Michigan | 48073 | — |
| Mercy Health Research | St Louis | Missouri | 63141 | — |
| Robert Wood Johnson Medical School | Piscataway | New Jersey | 08854 | — |
| Strong Center for Developmental Disabilities, University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Children's Hospital Medical Center of Akron | Akron | Ohio | 44308 | — |
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45229-3039 | — |
| Nisonger Center Ohio State University | Columbus | Ohio | 43210 | — |
| Merck Child Outpatient Clinic | Pittsburgh | Pennsylvania | 15203 | — |
| North San Antonio Healthcare Associates | San Antonio | Texas | 78217 | — |
| Autism Spectrum Treatment and Research Center | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00110708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2006 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00110708 live on ClinicalTrials.gov.